⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29118945 | 0.87 | — | — | |
| SCHEMBL910644 | 0.86 | DPP4 (0.36) | — | |
| SCHEMBL337473 | 0.85 | EPHX2 (0.30) | — | |
| SCHEMBL16977501 | 0.85 | EPHX2 (0.30) | — | |
| SCHEMBL17510167 | 0.85 | EPHX2 (0.30) | — | |
| SCHEMBL750103 | 0.82 | — | — | |
| SCHEMBL26537621 | 0.82 | — | — | |
| SCHEMBL26537620 | 0.82 | — | — | |
| SCHEMBL4569175 | 0.81 | — | — | |
| SCHEMBL12253464 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013755-B1 | PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2025-01-08 | — | — | EP | claimed |
| US-11420970-B1 | Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents | NOVARTIS AG (CH) | 2022-08-23 | — | — | US | claimed |
| CN-114478528-A | Aroyl-substituted tricyclic compound, preparation method and application thereof | 劲方医药科技(上海)有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20150291576-A1 | COMPOUNDS AND THEIR METHODS OF USE | SERVIER PHARMACEUTICALS LLC | 2015-10-15 | — | — | US | disclosed |
| US-9029531-B2 | Compounds and their methods of use | AGIOS PHARMACEUTICALS, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20140142081-A1 | COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC (US) | 2014-05-22 | — | — | US | disclosed |
| EP-1590491-B1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF SE (DE) | 2011-06-01 | — | — | EP | disclosed |
| EP-1590492-B1 | TANNING AGENTS AND PRESERVATIVES | BASF SE (DE) | 2009-04-15 | — | — | EP | disclosed |
| US-7410504-B2 | Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-12 | — | — | US | disclosed |
| US-7282066-B2 | Processes for preparing and using tanning agents and preservatives | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-16 | — | — | US | disclosed |
| US-20070101509-A1 | Method for the production of leather and semifinished products, and formulations that are suitable therefor | BASF AKIENGESELLSCHAFT (DE) | 2007-05-10 | — | — | US | disclosed |
| EP-1670957-A1 | METHOD FOR THE PRODUCTION OF LEATHER AND SEMIFINISHED PRODUCTS, AND FORMULATIONS THAT ARE SUITABLE THEREFOR | BASF Aktiengesellschaft (DE) | 2006-06-21 | — | — | EP | disclosed |
| US-20060101583-A1 | Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-18 | — | — | US | disclosed |
| US-20060053564-A1 | Tanning agents and preservatives | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | US | disclosed |
| EP-1590491-A1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF Aktiengesellschaft (DE) | 2005-11-02 | — | — | EP | disclosed |
| WO-2005031007-A1 | METHOD FOR THE PRODUCTION OF LEATHER AND SEMIFINISHED PRODUCTS, AND FORMULATIONS THAT ARE SUITABLE THEREFOR | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | WO | disclosed |
| WO-2004067781-A1 | ADDUCTS BASED ON CYCLIC COMPOUNDS AND THE USE THEREOF AS TANNING AGENTS AND CURING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | WO | disclosed |